<p>本文由 MarketWatch 自动生成，使用了 Automated Insights 的技术。</p>
<p>Corbus Pharmaceuticals Holdings Inc. (CRBP) 的股价周二下跌 2.17%，至 8.10 美元，股市整体交易情况严峻，纳斯达克综合指数下跌 1.43%，至 23,255.19 点，道琼斯工业平均指数下跌 0.34%，至 49,240.99 点。</p>
<p>Corbus Pharmaceuticals Holdings Inc. 的股价比其 52 周高点 20.56 美元低 60.60%，该高点是在 10 月 20 日达到的。</p>
<p>与一些竞争对手相比，该股表现不佳，周二 Vanda Pharmaceuticals Inc. (VNDA) 上涨 4.01%，至 8.05 美元，Fortress Biotech Inc. (FBIO) 下跌 1.90%，至 3.09 美元，Viking Therapeutics Inc. (VKTX) 下跌 1.70%，至 29.41 美元。</p>
<p>交易量（102,539）比其 50 天平均交易量 314,944 低 212,405。</p>
<p>数据来源：道琼斯市场数据，FactSet。数据汇编于 2026 年 2 月 3 日。</p>
<p>此内容由 MarketWatch 创建，MarketWatch 由道琼斯公司运营。MarketWatch 独立于道琼斯新闻通讯和华尔街日报发布。</p>
<p>（完）道琼斯新闻通讯</p>
<p>02-03-26 1723ET</p>

IBBQ

标普生物技术 ETF - SPDR

纽交所高增长板生物技术指数 ETF - First Trust

<p>Corbus Pharmaceuticals Holdings Inc. (CRBP) 的股价在周二下跌了 2.17%，至 8.10 美元，表现不及竞争对手，且整体股市下滑。纳斯达克综合指数下跌了 1.43%，而道琼斯工业平均指数下跌了 0.34%。Corbus 的股价目前比其 52 周高点 20.56 美元低了 60.60%。相比之下，Vanda Pharmaceuticals Inc. 上涨了 4.01%，而 Fortress Biotech Inc. 和 Viking Therapeutics Inc. 则小幅下跌。交易量显著低于 50 天的平均水平</p>

<p>This article was automatically generated by MarketWatch using technology from Automated Insights.</p>
<div class="lb-trans"><p>本文由 MarketWatch 自动生成，使用了 Automated Insights 的技术。</p>
</div><p>Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slid 2.17% to $8.10 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.43% to 23,255.19 and Dow Jones Industrial Average falling 0.34% to 49,240.99.</p>
<div class="lb-trans"><p>Corbus Pharmaceuticals Holdings Inc. (CRBP) 的股价周二下跌 2.17%，至 8.10 美元，股市整体交易情况严峻，纳斯达克综合指数下跌 1.43%，至 23,255.19 点，道琼斯工业平均指数下跌 0.34%，至 49,240.99 点。</p>
</div><p>Corbus Pharmaceuticals Holdings Inc. closed 60.60% short of its 52-week high of $20.56, which the company reached on October 20th.</p>
<div class="lb-trans"><p>Corbus Pharmaceuticals Holdings Inc. 的股价比其 52 周高点 20.56 美元低 60.60%，该高点是在 10 月 20 日达到的。</p>
</div><p>The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 4.01% to $8.05, Fortress Biotech Inc. (FBIO) fell 1.90% to $3.09, and Viking Therapeutics Inc. (VKTX) fell 1.70% to $29.41.</p>
<div class="lb-trans"><p>与一些竞争对手相比，该股表现不佳，周二 Vanda Pharmaceuticals Inc. (VNDA) 上涨 4.01%，至 8.05 美元，Fortress Biotech Inc. (FBIO) 下跌 1.90%，至 3.09 美元，Viking Therapeutics Inc. (VKTX) 下跌 1.70%，至 29.41 美元。</p>
</div><p>Trading volume (102,539) remained 212,405 below its 50-day average volume of 314,944.</p>
<div class="lb-trans"><p>交易量（102,539）比其 50 天平均交易量 314,944 低 212,405。</p>
</div><p>Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2026.</p>
<div class="lb-trans"><p>数据来源：道琼斯市场数据，FactSet。数据汇编于 2026 年 2 月 3 日。</p>
</div><p>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</p>
<div class="lb-trans"><p>此内容由 MarketWatch 创建，MarketWatch 由道琼斯公司运营。MarketWatch 独立于道琼斯新闻通讯和华尔街日报发布。</p>
</div><p>(END) Dow Jones Newswires</p>
<div class="lb-trans"><p>（完）道琼斯新闻通讯</p>
</div><p>02-03-26 1723ET</p>
<div class="lb-trans"><p>02-03-26 1723ET</p>
</div>

Corbus 制药控股公司的股票在周二的表现逊于竞争对手